The pro-apoptotic effect of the AS-IV/propofol combination on NSCLC cells was further enhanced by treatment with the autophagy inhibitor 3-MA, as shown by the decreased level of Bcl-2 and increased level of cleaved caspase 3 (Figure 6a–e). The gene discussed is BCL2; the disease is non-small cell lung carcinoma.